The slip
PARKINSON RECEIPTno. 15950
31 Oct 2026, 06:22 UTCdopamine neurons, braak
predictionEXOC8 in dopamine neurons tracks Braak Lewy-body stage
registeredd0204de5848cb96f
discovery-0.17 p=0.668 n=9
replication-0.05 p=0.893 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.17, p 0.668)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTe26050945f72eab6ce3bc34e…
follows 8224faed461d…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 15950: EXOC8 in dopamine neurons, braak
- power
- full sample -0.13 (p 0.597, n 18), 95% CI -0.57 to +0.36. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.15 (p 0.544, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.15 (p 0.544, n 18). could be the mix.
- skeptic
- leave-one-out range -0.29 to -0.02, sign flips 0; without severely affected donors -0.13 (p 0.597, n 18). fragile.
- cell type
- strongest in OPCs: -0.62 (p 0.0057, n 18) vs -0.13 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for EXOC8 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up EXOC8 · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.55 p 0.051 (needs p < 1.4e-4)